169 related articles for article (PubMed ID: 37522568)
1. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
[TBL] [Abstract][Full Text] [Related]
2. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
Chen M; Zhu X; Zhang L; Zhao D
BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
[TBL] [Abstract][Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
4. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
[TBL] [Abstract][Full Text] [Related]
5. High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
Tan Y; Chen Q; Xing Y; Zhang C; Pan S; An W; Xu H
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739392
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
7. Identification of latent biomarkers in connection with progression and prognosis in oral cancer by comprehensive bioinformatics analysis.
Reyimu A; Chen Y; Song X; Zhou W; Dai J; Jiang F
World J Surg Oncol; 2021 Aug; 19(1):240. PubMed ID: 34384424
[TBL] [Abstract][Full Text] [Related]
8. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
9. COL5A2 as a potential clinical biomarker for gastric cancer and renal metastasis.
Ding YL; Sun SF; Zhao GL
Medicine (Baltimore); 2021 Feb; 100(7):e24561. PubMed ID: 33607786
[TBL] [Abstract][Full Text] [Related]
10. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
Zhang C; Zhang CD; Ma MH; Dai DQ
World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
[TBL] [Abstract][Full Text] [Related]
11. Analysis and application of RNA binding protein gene pairs to predict the prognosis of gastric cancer.
Ning ZK; Tian HK; Liu J; Hu CG; Liu ZT; Li H; Zong Z
Heliyon; 2023 Jul; 9(7):e18242. PubMed ID: 37539127
[TBL] [Abstract][Full Text] [Related]
12. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
13. Comprehensive analysis to identify pseudogenes/lncRNAs-hsa-miR-200b-3p-COL5A2 network as a prognostic biomarker in gastric cancer.
Li P; Ji W; Wei Z; Wang X; Qiao G; Gao C; Wang Y; Qi F
Hereditas; 2022 Nov; 159(1):43. PubMed ID: 36447214
[TBL] [Abstract][Full Text] [Related]
14. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
16. LUM as a novel prognostic marker and its correlation with immune infiltration in gastric cancer: a study based on immunohistochemical analysis and bioinformatics.
Xu W; Chen S; Jiang Q; He J; Zhang F; Wang Z; Ruan C; Shi B
BMC Gastroenterol; 2023 Dec; 23(1):455. PubMed ID: 38129820
[TBL] [Abstract][Full Text] [Related]
17. ENTPD1-AS1-miR-144-3p-mediated high expression of
Yuan HM; Pu XF; Wu H; Wu C
World J Gastrointest Oncol; 2023 Jul; 15(7):1182-1199. PubMed ID: 37546560
[TBL] [Abstract][Full Text] [Related]
18. Aberrant brain-expressed X-linked 4 (BEX4) expression is a novel prognostic biomarker in gastric cancer.
Zhu C; Xiao D
Medicine (Baltimore); 2020 Nov; 99(47):e23133. PubMed ID: 33217815
[TBL] [Abstract][Full Text] [Related]
19. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes.
Bai Y; Wei C; Zhong Y; Zhang Y; Long J; Huang S; Xie F; Tian Y; Wang X; Zhao H
Int J Biol Sci; 2020; 16(7):1153-1165. PubMed ID: 32174791
[No Abstract] [Full Text] [Related]
[Next] [New Search]
